Late Complications in Eyes With Posterior Vitreous Detachment
By Jean Shaw
Selected by Andrew P. Schachat, MD
Journal Highlights
Ophthalmology Retina, March 2023
Download PDF
Patel et al. set out to examine the incidence of delayed complications of posterior vitreous detachment (PVD) and to identify any patient-specific risk factors. They found that the rate of any complication was 25% and that the rates of isolated vitreous hemorrhage, retinal breaks without detachment, and retinal detachments (RDs) were 13.1%, 16%, and 4.2%, respectively. However, while the majority of complications were noted at presentation, a significant proportion of each type was first noted within the six-month follow-up period.
For this retrospective observational study, the researchers used the Vestrum Health database to identify eyes with acute PVDs that occurred between 2015 and 2019. All told, 9,635 eyes were included; of these, 3,990 were phakic, 2,225 were pseudophakic, and 1,252 had documented lattice/peripheral retinal degeneration. (Of note, some charts did not list whether an eye was phakic or pseudophakic.) The patients’ mean age was 63 years, and a majority (51.4%) were female. Outcomes measured included the rate of complications at initial presentation and at six months as well as the days to presentation with a complication.
The average time to any complication was 39.4 days. Diagnosis at presentation and complications noted during follow-up were as follows:
- Isolated vitreous hemorrhage. Of 1,261 eyes with an isolated vitreous hemorrhage, 652 (51.7%) were diagnosed at presentation. During follow-up, an additional 101 eyes (8%) developed this complication.
- Retinal breaks without detachment. Of 1,539 eyes that had retinal breaks without detachment, 1,172 (76.2%) were diagnosed at presentation. By six months of follow-up, another 295 (19.2%) had developed this complication.
- RD. Of 403 eyes with an RD, 299 (74.2%) were noted at presentation. During follow-up, another 104 (25.8%) developed an RD.
With regard to patient-specific risk factors, men were more likely to experience delayed complications than were women (30% vs. 21.7%, respectively; p < .001). The rate of any complication among pseudophakic eyes was 25% and 20.7% in phakic eyes (p < .001). Among eyes with lattice/peripheral retinal degeneration, 44.2% experienced complications during follow-up. Similarly, a history of retinal breaks or RDs in the fellow eye was associated with a greater rate of complications (p < .0001 for retinal breaks; p < .02 for RDs) in the eye with a PVD.
Not all eyes had isolated pathology; for instance, 401 eyes with a vitreous hemorrhage at presentation also had a retinal break without RD at this point, while another 107 had a vitreous hemorrhage and an RD at presentation.
Given these findings, the authors recommend follow-up at the four- to six-week mark in all patients, counseling regarding symptoms of progression, and extended follow-up around the three-month mark in male patients and in those eyes found to be at greater risk of delayed complications in this study.
The original article can be found here.